The University of Queensland's BASE facility – within the Australian Institute for Bioengineering and Nanotechnology (AIBN) – and Brisbane-based biotechnology company Vaxxas have been announced as ...
Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, has been named a C ...
The Los Angeles fires are shaping up to be one of the most expensive disasters in US history, and due to the global nature of the insurance industry, the costs may be felt in Australia.